| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $623.0M | +26.6% |
| R&D Expense | $70.2M | +5.4% |
| SG&A Expense | $135.5M | +7.7% |
| Operating Income | $11.3M | +255.7% |
| Interest Expense | $3.5M | +600.0% |
| Pre-tax Income | $21.4M | +1052.7% |
| Income Tax | $7.9M | +863.7% |
| Net Income | $13.5M | +365.4% |
| EPS (Basic) | $0.11 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $330.3M | -33.3% |
| Short-term Investments | $24.7M | -78.7% |
| Accounts Receivable | $34.8M | +46.7% |
| Current Assets | $602.3M | -21.1% |
| Total Assets | $1.25B | +11.7% |
| Current Liabilities | $401.8M | +38.6% |
| Total Liabilities | $418.1M | +35.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $100.2M | +9.5% |
| Capital Expenditures | $1.4M | +46.1% |
| Investing Cash Flow | -$194.2M | +10.0% |
| Financing Cash Flow | -$78.4M | -108.3% |
| Free Cash Flow | $98.8M | +9.1% |
| +450.0% |
| EPS (Diluted) | $0.11 | +450.0% |
| Stockholders' Equity |
| $835.2M |
| +2.5% |